Cargando…
The LINC00365/SCGB2A1 (Mammaglobin B) Axis Down-Regulates NF-κB Signaling and Is Associated with the Progression of Gastric Cancer
PURPOSE: A lack of early diagnostic biomarkers and therapeutic targets has led to poor prognosis for gastric cancer patients. However, the analysis of cancer-associated genomic data has been shown to be effective in identifying potential markers. Recently, the long non-coding RNA LINC00365 and SCGB2...
Autores principales: | Yan, Xiao-Yu, Zhang, Juan-Juan, Zhong, Xin-Ru, Yu, Si-Hang, Xu, Long, Tian, Rui, Sun, Lian-Kun, Su, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995300/ https://www.ncbi.nlm.nih.gov/pubmed/32095083 http://dx.doi.org/10.2147/CMAR.S223699 |
Ejemplares similares
-
LINC00365-SCGB2A1 axis inhibits the viability of breast cancer through targeting NF-κB signaling
por: Zhang, Lichao, et al.
Publicado: (2020) -
Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies
por: Zafrakas, Menelaos, et al.
Publicado: (2006) -
Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
por: Bellone, S, et al.
Publicado: (2013) -
In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells
por: Hassan, Eman M., et al.
Publicado: (2017) -
Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κB
por: Kusumastuti, Ratih, et al.
Publicado: (2022)